98%
921
2 minutes
20
Parkinsonism-dominant multiple system atrophy (MSA-P) is typically a progressive disorder with poor responsiveness to levodopa and an unfavorable prognosis. However, in certain cases, the response to levodopa can be as robust as in Parkinson's disease (PD), with severe motor fluctuations developing during treatment. Unlike PD, no established therapy exists to maintain activities of daily living (ADLs) in such patients. We present three cases of young-onset MSA-P who demonstrated sustained levodopa responsiveness and were treated with levodopa-carbidopa intestinal gel (LCIG) following the emergence of disabling motor fluctuations. In all three patients, parkinsonism was the predominant symptom from onset until LCIG initiation, with only mild autonomic or cerebellar symptoms. Prior to LCIG introduction, their motor complications closely resembled those of advanced PD. LCIG therapy successfully reduced "off" time and dyskinesia in all cases. However, long-term follow-up revealed a gradual decline in ADLs due to disease progression. These cases suggest that LCIG may be a valuable treatment option for selected MSA-P patients with preserved levodopa responsiveness.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC12334818 | PMC |
http://dx.doi.org/10.1177/17562864251360048 | DOI Listing |
Aging Clin Exp Res
September 2025
Division of Rehabilitation Sciences, Department of Health Sciences, Medical School, Nagoya City University, Nagoya, Japan.
Objective: This study aimed to investigate the relationship between ankle joint function and walking performance in older adults by assessing qualitative ankle functions through torque fluctuation analysis and tibialis anterior (TA) intramuscular coherence during isometric dorsiflexion.
Methods: Thirty-eight community-dwelling older adults participated in this study. Ankle torque fluctuations and intramuscular coherence were evaluated during a dorsiflexion task at 30% of maximum voluntary torque (MVT).
Clin Spine Surg
September 2025
Department of Orthopaedics and Physical Medicine, Medical University of South Carolina, Jonathan Lucas Street, Charleston, SC.
Study Design: Retrospective review.
Objective: Examine the utility of intraoperative neuromonitoring (IONM) in anterior cervical spine procedures for myelopathy in informing intraoperative interventions.
Summary Of Background Data: The routine use of IONM in anterior cervical spine procedures for myelopathy remains controversial, with poorly defined indications and limited evidence validating protocols for managing intraoperative alerts.
Neurol Res Pract
September 2025
Department of Neurology, Philipps-University Marburg, Biegenstraße 10, 35032, Marburg, Germany.
Background: Parkinson's disease (PD) multimodal complex treatment (PD-MCT) is an inpatient therapeutic programme specifically designed for patients exhibiting parkinsonian symptoms. Established in Germany, this comprehensive approach addresses the multifaceted challenges associated with the management of PD, particularly in advanced stages or when complications such as motor fluctuations, dyskinesia, or non-motor symptoms become pronounced. The programme integrates pharmacological optimization, physiotherapy, occupational therapy, speech therapy, and psychological support, among other complementary therapies, to enhance patient outcomes holistically.
View Article and Find Full Text PDFBackground And Aims: Parkinson's disease (PD) is a progressive neurological condition that consists of both motor and non-motor symptoms that considerably deteriorate the quality of life. Pharmacological treatments, primarily levodopa, have been used to manage PD. However, side effects such as dyskinesias and motor fluctuations frequently limit their long-term effectiveness.
View Article and Find Full Text PDFJ Neural Transm (Vienna)
September 2025
Department of Medical Sciences, Neurology, Uppsala University, Uppsala, Sweden.
Enhancing levodopa efficacy through peripheral COMT inhibition and using continuous infusion are both established strategies for managing motor fluctuations. Both approaches aim to improve the pharmacokinetics of levodopa in order to maintain a steady delivery of levodopa to the brain, avoid the deep troughs in levodopa plasma concentrations associated with oral levodopa delivery, and thereby reduce OFF time. In this review, we describe the pharmacologic rationale for combining COMT inhibition with entacapone and continuous dopaminergic delivery that led to the development of levodopa/entacapone/carbidopa intestinal gel (LECIG).
View Article and Find Full Text PDF